PROCATHEPSIN B AND ENDOGENOUS INHIBITORS OF CYSTEINE PROTEASES IN TUMORS OF REPRODUCTIVE SYSTEM
- 作者: Gashenko E.1, Lebedeva V.2, Russkikh G.3, Tsykalenko E.2, Pupyshev A.1, Brak I.1, Korolenko T.1
-
隶属关系:
- Scientific Research Institute of Physiology & Basic Medicine
- Novosibirsk State Medical University
- Scientific Research Institute of Biochemistry
- 期: 卷 22, 编号 5 (2017)
- 页面: 261-265
- 栏目: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/40376
- DOI: https://doi.org/10.18821/1028-9984-2017-22-5-261-265
- ID: 40376
如何引用文章
全文:
详细
作者简介
Elena Gashenko
Scientific Research Institute of Physiology & Basic Medicine
Email: elena.gashenko@gmail.com
MD, Researcher of the Laboratory of Experimental Models of Neuron Degenerative Processes. Novosibirsk, 630117, Russian Federation Novosibirsk, 630117, Russian Federation
V. Lebedeva
Novosibirsk State Medical UniversityNovosibirsk, 630091, Russian Federation
G. Russkikh
Scientific Research Institute of BiochemistryNovosibirsk, 630117, Russian Federation
E. Tsykalenko
Novosibirsk State Medical UniversityNovosibirsk, 630091, Russian Federation
A. Pupyshev
Scientific Research Institute of Physiology & Basic MedicineNovosibirsk, 630117, Russian Federation
I. Brak
Scientific Research Institute of Physiology & Basic MedicineNovosibirsk, 630117, Russian Federation
T. Korolenko
Scientific Research Institute of Physiology & Basic MedicineNovosibirsk, 630117, Russian Federation
参考
- Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИРЦ» Минздрава России; 2017.
- Joyce J.A., Baruch A., Chehade K., Meyer-Morse N., Giraudo E., Tsai F.Y. et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell. 2004; 5(5): 443-53.
- Elliott E., Sloane B.F. The procathepsin B in cancer. Perspect. Drug Des. 1996; (6): 12-32.
- Tan G.J., Peng Z.K., Lu J.P., Tang F.Q. Cathepsins mediate tumor metastasis. World J. Biol. Chem. 2013; 26; 4(4): 91-101.
- Turk V., Stoka V., Vasiljeva O., Renko M., Sun T., Turk B., Turk D. Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochim. Biophys. Acta. 2012; 1824(1): 68-88.
- Короленко Т.А. Цистатины - биологическая роль и нарушения в патологии. Вестник Российской АМН. 2008; (4): 43-7.
- Turk V., Stoka V., Turk D. Cystatins: biochemical and structural properties, and medical relevance. Front. Biosci. 2008, 13, 5406-20.
- Levičar N., Kos J., Blejec A., Golouh R., Vrhovec I., Frkovič-Grazio S., Lah T. Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients. Cancer Det. Prev. 2002; 26: 42-9.
- Спирина Л.В., Кондакова И.В. Роль специфического внутриклеточного протеолиза в онкогенезе. Вопр. онкол. 2008; 54(6): 690-4.
- Korolenko T.A., Kisarova Y.A, Filjushina E.E., Machova E. In: Macrophages: Life Cycle, Functions and Diseases (Takahashi R., Kai H. Eds.). New York: Nova Science Publishers; 2012: 249-76.
- Гашенко Е.А., Лебедева В.А., Короленко Т.А., Гаврилова Н.И., Филатова Т.Г., Цикаленко Е.А. и др. Концентрация прокатепсина В и ингибитора цистеиновых протеаз в биологических жидкостях при развитии опухолей. Бюллетень СО РАМН. 2010; 30(4):110-5.
- Kos J., Krasovec M., Cimerman N., Nielsen H.J., Christensen I.J., Brünner N. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin. Cancer Res. 2000; 6(2): 505-11.
- Wegiel B., Jiborn T., Abrahamson M., Helczynski L., Otterbein L., Persson J.L., Bjartell A. Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cell via MAPK/Erk and androgen receptor pathways. PLoS One. 2009; 4(11): e7953.
- Gashenko E.A., Lebedeva V.A., Brak I.V., Tsykalenko E.A., Vinokurova G.V., Korolenko T.A. Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer». Int. J. Circumpolar Health. 2013, 72: 21215.
- Kolwijck E., Kos J., Obermajer N., Span P.N., Thomas C.M., Massuger L.F. et al. The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer. Eur. J. Clin. Invest. 2010; 40: 591-9.
- Lah T.T., Kokalj-Kunovar M., Kastelic L., Babnik J., Stolfa A., Rainer S. et al. Cystatins and stefins in ascites fluid from ovarian carcinoma. Cancer Lett. 1992; 61: 243-53.
- Nishikawa H., Ozaki Y., Nakanishi T., Blomgren K., Tada T., Arakawa A. et al. The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer. Gynecol. Oncol. 2004; 92(3): 881-6.
- Takaya A., Peng W.-X., Ishino K., Kudo M., Yamamoto T., Wada R. et al. Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma. Int. J. Oncol. 2015; 46(4): 1573-81. doi: 10.3892/ijo.2015.2858
- Kolwijck E., Massuger L.F., Thomas C.M., Span P.N., Krasovec M., Kos J. et al. Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors. J. Cancer Res. Clin. Oncol. 2010; 136: 771-8.
- Mussap M., Plebani M. Biochemistry and clinical role of human cystatin C. Crit. Rev. Clin. Lab. Sci. 2004; 41(5-6): 467-550.
- Kos J., Lah T.T. Cysteine proteases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). Oncol. Rep. 1998; 5(6): 1349-61.
- Berdowska I. Cysteine proteases as disease markers. Clin. Chim. Acta. 2004; 342(1-2): 41-69.